Logo image of SIBN

SI-BONE INC (SIBN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SIBN - US8257041090 - Common Stock

19.46 USD
+0.28 (+1.46%)
Last: 12/4/2025, 1:46:57 PM
Fundamental Rating

3

Taking everything into account, SIBN scores 3 out of 10 in our fundamental rating. SIBN was compared to 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of SIBN is average, but there are quite some concerns on its profitability. While showing a medium growth rate, SIBN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SIBN has reported negative net income.
SIBN had a negative operating cash flow in the past year.
SIBN had negative earnings in each of the past 5 years.
In the past 5 years SIBN always reported negative operating cash flow.
SIBN Yearly Net Income VS EBIT VS OCF VS FCFSIBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

SIBN has a better Return On Assets (-9.29%) than 61.70% of its industry peers.
The Return On Equity of SIBN (-12.64%) is better than 65.96% of its industry peers.
Industry RankSector Rank
ROA -9.29%
ROE -12.64%
ROIC N/A
ROA(3y)-23.71%
ROA(5y)-24.08%
ROE(3y)-35.49%
ROE(5y)-34.87%
ROIC(3y)N/A
ROIC(5y)N/A
SIBN Yearly ROA, ROE, ROICSIBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

The Gross Margin of SIBN (79.62%) is better than 92.02% of its industry peers.
In the last couple of years the Gross Margin of SIBN has declined.
SIBN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.65%
GM growth 5Y-2.54%
SIBN Yearly Profit, Operating, Gross MarginsSIBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

6

2. Health

2.1 Basic Checks

SIBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
SIBN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SIBN has been increased compared to 5 years ago.
The debt/assets ratio for SIBN has been reduced compared to a year ago.
SIBN Yearly Shares OutstandingSIBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SIBN Yearly Total Debt VS Total AssetsSIBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

SIBN has an Altman-Z score of 6.77. This indicates that SIBN is financially healthy and has little risk of bankruptcy at the moment.
SIBN has a Altman-Z score of 6.77. This is amongst the best in the industry. SIBN outperforms 82.45% of its industry peers.
SIBN has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
SIBN has a Debt to Equity ratio of 0.21. This is comparable to the rest of the industry: SIBN outperforms 59.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 6.77
ROIC/WACCN/A
WACC8.67%
SIBN Yearly LT Debt VS Equity VS FCFSIBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 7.97 indicates that SIBN has no problem at all paying its short term obligations.
SIBN has a better Current ratio (7.97) than 89.36% of its industry peers.
A Quick Ratio of 6.62 indicates that SIBN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 6.62, SIBN belongs to the top of the industry, outperforming 88.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.97
Quick Ratio 6.62
SIBN Yearly Current Assets VS Current LiabilitesSIBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

SIBN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.57%, which is quite impressive.
SIBN shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.27%.
The Revenue has been growing by 19.96% on average over the past years. This is quite good.
EPS 1Y (TTM)44.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.25%
Revenue 1Y (TTM)23.27%
Revenue growth 3Y22.84%
Revenue growth 5Y19.96%
Sales Q2Q%20.61%

3.2 Future

SIBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.39% yearly.
Based on estimates for the next years, SIBN will show a quite strong growth in Revenue. The Revenue will grow by 16.30% on average per year.
EPS Next Y19.56%
EPS Next 2Y16.01%
EPS Next 3Y14.39%
EPS Next 5YN/A
Revenue Next Year18.29%
Revenue Next 2Y17.38%
Revenue Next 3Y16.43%
Revenue Next 5Y16.3%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SIBN Yearly Revenue VS EstimatesSIBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
SIBN Yearly EPS VS EstimatesSIBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SIBN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SIBN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SIBN Price Earnings VS Forward Price EarningsSIBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SIBN Per share dataSIBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

SIBN's earnings are expected to grow with 14.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.01%
EPS Next 3Y14.39%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SIBN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SI-BONE INC

NASDAQ:SIBN (12/4/2025, 1:46:57 PM)

19.46

+0.28 (+1.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)01-12 2026-01-12/amc
Inst Owners91.29%
Inst Owner Change1.17%
Ins Owners3.01%
Ins Owner Change0.27%
Market Cap844.37M
Revenue(TTM)193.58M
Net Income(TTM)-21.75M
Analysts84
Price Target25.39 (30.47%)
Short Float %7.18%
Short Ratio5.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.24%
Min EPS beat(2)25.4%
Max EPS beat(2)35.08%
EPS beat(4)4
Avg EPS beat(4)30.34%
Min EPS beat(4)25.4%
Max EPS beat(4)35.08%
EPS beat(8)8
Avg EPS beat(8)24.69%
EPS beat(12)12
Avg EPS beat(12)24.73%
EPS beat(16)13
Avg EPS beat(16)17.22%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.9%
Max Revenue beat(2)2.22%
Revenue beat(4)3
Avg Revenue beat(4)1.07%
Min Revenue beat(4)-0.9%
Max Revenue beat(4)2.63%
Revenue beat(8)6
Avg Revenue beat(8)0.9%
Revenue beat(12)10
Avg Revenue beat(12)2.07%
Revenue beat(16)12
Avg Revenue beat(16)1.46%
PT rev (1m)-0.44%
PT rev (3m)-0.44%
EPS NQ rev (1m)8.39%
EPS NQ rev (3m)6.47%
EPS NY rev (1m)-0.55%
EPS NY rev (3m)-0.55%
Revenue NQ rev (1m)0.8%
Revenue NQ rev (3m)0.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.36
P/FCF N/A
P/OCF N/A
P/B 4.91
P/tB 4.91
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS4.46
BVpS3.97
TBVpS3.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.29%
ROE -12.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.62%
FCFM N/A
ROA(3y)-23.71%
ROA(5y)-24.08%
ROE(3y)-35.49%
ROE(5y)-34.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.65%
GM growth 5Y-2.54%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 175.72%
Cap/Sales 4.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.97
Quick Ratio 6.62
Altman-Z 6.77
F-Score5
WACC8.67%
ROIC/WACCN/A
Cap/Depr(3y)219.68%
Cap/Depr(5y)238.27%
Cap/Sales(3y)6.94%
Cap/Sales(5y)6.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.25%
EPS Next Y19.56%
EPS Next 2Y16.01%
EPS Next 3Y14.39%
EPS Next 5YN/A
Revenue 1Y (TTM)23.27%
Revenue growth 3Y22.84%
Revenue growth 5Y19.96%
Sales Q2Q%20.61%
Revenue Next Year18.29%
Revenue Next 2Y17.38%
Revenue Next 3Y16.43%
Revenue Next 5Y16.3%
EBIT growth 1Y39.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year110.65%
EBIT Next 3Y36.68%
EBIT Next 5Y31.83%
FCF growth 1Y66.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.72%
OCF growth 3YN/A
OCF growth 5YN/A

SI-BONE INC / SIBN FAQ

What is the ChartMill fundamental rating of SI-BONE INC (SIBN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SIBN.


What is the valuation status of SI-BONE INC (SIBN) stock?

ChartMill assigns a valuation rating of 0 / 10 to SI-BONE INC (SIBN). This can be considered as Overvalued.


How profitable is SI-BONE INC (SIBN) stock?

SI-BONE INC (SIBN) has a profitability rating of 2 / 10.


What is the expected EPS growth for SI-BONE INC (SIBN) stock?

The Earnings per Share (EPS) of SI-BONE INC (SIBN) is expected to grow by 19.56% in the next year.